A detailed history of Kenfarb & Co. transactions in Eli Lilly & CO stock. As of the latest transaction made, Kenfarb & Co. holds 3,860 shares of LLY stock, worth $2.81 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares
3,860
Previous 4,270 9.6%
Holding current value
$2.81 Million
Previous $2 Million 3.55%
% of portfolio
1.91%
Previous 1.76%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $178,227 - $245,712
-410 Reduced 9.6%
3,860 $2.07 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $10,522 - $14,069
-30 Reduced 0.7%
4,270 $2 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $31,063 - $36,482
-100 Reduced 2.27%
4,300 $1.48 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $11,859 - $13,514
40 Added 0.92%
4,400 $1.42 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $117,345 - $145,830
-500 Reduced 10.29%
4,360 $1.25 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $1.09 Million - $1.36 Million
4,860 New
4,860 $1.34 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $691B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kenfarb & Co. Portfolio

Follow Kenfarb & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kenfarb & Co., based on Form 13F filings with the SEC.

News

Stay updated on Kenfarb & Co. with notifications on news.